The Global Scientific Conference on Clinical Trial Design and Outcome Measures for Inherited Retinal Dystrophies Associated with Mutations in the RDH12 Gene was hosted by the RDH12 Alliance in partnership with Foundation Fighting Blindness and Hope in Focus and brought together key opinion leaders in the field of inherited retinal diseases (IRDs) from academic and clinical settings, regulatory agencies, biotechnology and pharmaceutical industry representatives, and patient organizations. Here, RDH12 is linked to inherited retinal dystrophy.